Literature DB >> 8638735

In situ activation of mouse alveolar macrophages by aerosolized liposomal IFN-gamma and muramyl tripeptide.

P Goldbach1, S Dumont, R Kessler, P Poindron, A Stamm.   

Abstract

Interferon-gamma (IFN-gamma) was entrapped with an efficiency of 30-40% in muramyl tripeptide-containing liposomes by a freeze-thawing procedure. A microcytotoxicity assay was developed to measure the tumoricidal activity of mouse alveolar macrophages (AM) against tumoral target cells with a colorimetric viability test. Free IFN-gamma and liposomal muramyl tripeptide phosphatidylethanolamine (MTP-PE) were found to be only slightly effective to activate in vitro AM, whereas encapsulation of both INF-gamma and MTP-PE within the same liposomes produced higher activation of AM. Aerosolized IFN-gamma and liposomal immunomodulators enhanced antitumor properties of AM recovered in mice 24 h postinhalation. Whereas free IFN-gamma also induced a substantial activation of peritoneal macrophages, liposomal encapsulation significantly reduced the systemic activity of inhaled immunomodulators. This approach provides a useful model for the compartmentalized organ-specific activation of AM in mice.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8638735     DOI: 10.1152/ajplung.1996.270.3.L429

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  3 in total

Review 1.  Mifamurtide for the treatment of nonmetastatic osteosarcoma.

Authors:  Kosei Ando; Kanji Mori; Nedège Corradini; Françoise Redini; Dominique Heymann
Journal:  Expert Opin Pharmacother       Date:  2011-02       Impact factor: 3.889

Review 2.  Particle-mediated delivery of cytokines for immunotherapy.

Authors:  David A Christian; Christopher A Hunter
Journal:  Immunotherapy       Date:  2012-04       Impact factor: 4.196

3.  Macrophages inhibit human osteosarcoma cell growth after activation with the bacterial cell wall derivative liposomal muramyl tripeptide in combination with interferon-γ.

Authors:  Jens H W Pahl; Kitty M C Kwappenberg; Eleni M Varypataki; Susy J Santos; Marieke L Kuijjer; Susan Mohamed; Juul T Wijnen; Maarten J D van Tol; Anne-Marie Cleton-Jansen; R Maarten Egeler; Wim Jiskoot; Arjan C Lankester; Marco W Schilham
Journal:  J Exp Clin Cancer Res       Date:  2014-03-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.